EUVIMEDEUVIMED entdecken
Crossref

Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway

Xiaodan Bao, Youying Tang, Yishan Lv, Siyu Fu, Liu Yang, Yuchi Chen, Mingyuan Zhou, Bingqi Zhu, Zhishan Ding, Fangmei Zhou

International Immunopharmacology · 2024-08 · 137 · 112404

DOI: 10.1016/j.intimp.2024.112404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-08. Verfasst von Xiaodan Bao und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Electronic address: …. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Intestinal Barrier Function, Intestinal Mucosa, Polysaccharides. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is characterized by a chronic and protracted course and often leads to a poor prognosis. Patients with this condition often experience postoperative complications, further complicating the management of their condition. Tetrastigma hemsleyanum polysaccharide (THP) has demonstrated considerable potential as a treatment for inflammatory bowel disease. However, its underlying mechanism in the treatment of UC remains unclear. This study systematically and comprehensively investigated the effects of THP on dextran sulfate-induced UC mice and illustrated its specific mechanism of action. The colon and spleen in UC mice were restored after THP treatment. The levels of key markers, such as secretory immunoglobulin A, β-defensin, and mucin-2 were increased, collagen deposition and epithelial cell apoptosis were decreased. Notably, THP administration led to increased levels of Ki67 and tight junction proteins in colon tissue and reduced colon tissue permeability. THP contributed to the restored balance of intestinal flora. Furthermore, THP downregulated the expressions of the proinflammatory cytokines interleukin (IL)-6, tumor necrosis factor (TNF)-α, and IL-17 and promoted those of the regulatory factors forkhead box protein P3. It also exerted anti-inflammatory effects by promoting suppressor of cytokine signaling (SOCS1) expression and inhibiting the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway. Our results demonstrated that THP had an efficacy comparable to that of JAK inhibitor in treating UC. In addition, THP might play a role in UC therapy through modulation of the SOCS1/JAK2/STAT3 signaling pathway and remodeling of the intestinal mucosal barrier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeIntestinal Barrier FunctionIntestinal MucosaPolysaccharidesSignal TransductionVitaceaeAnimalsMaleMiceAnti-Inflammatory AgentsColonCytokinesDextran SulfateDisease Models, AnimalJanus Kinase 2Mice, Inbred C57BLSTAT3 Transcription FactorSuppressor of Cytokine Signaling 1 Protein

Stichwörter der Autor:innen

Intestinal mucosal barrier functionJAK/STAT pathwayTetrastigma hemsleyanum polysaccharideUlcerative colitis

Substanzen

Anti-Inflammatory AgentsCytokinesDextran SulfateJak2 protein, mouseJanus Kinase 2PolysaccharidesSocs1 protein, mouseStat3 protein, mouseSTAT3 Transcription FactorSuppressor of Cytokine Signaling 1 Protein

Autor:innen und Institutionen

  • School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Electronic address: bxdfanfan@163.com.
  • School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Electronic address: tyy4025@163.com.
  • School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Electronic address: lvyishan2022@163.com.
  • School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Electronic address: fsy516120162@163.com.
  • School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Electronic address: 17816763897@163.com.
  • School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Electronic address: btcyc@sina.com.

Zitieren

APA

Bao, X., Tang, Y., Lv, Y., Fu, S., Yang, L., Chen, Y., Zhou, M., Zhu, B., Ding, Z., & Zhou, F. (2024). Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway. International Immunopharmacology, 137, 112404. https://doi.org/10.1016/j.intimp.2024.112404

Vancouver

Bao X, Tang Y, Lv Y, Fu S, Yang L, Chen Y, et al. Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway. International Immunopharmacology. 2024;137:112404. doi:10.1016/j.intimp.2024.112404

BibTeX
@article{Bao2024,
  author = {Bao, Xiaodan and Tang, Youying and Lv, Yishan and Fu, Siyu and Yang, Liu and Chen, Yuchi and Zhou, Mingyuan and Zhu, Bingqi and Ding, Zhishan and Zhou, Fangmei},
  title = {Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {137},
  pages = {112404},
  doi = {10.1016/j.intimp.2024.112404}
}
Kostenlos starten →